SCHEMBL6515705

SCHEMBL6515705

COc1ccc([Se]c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.77
CA2 P00918 4/20 0.77
NPC1 O15118 1/20 0.57
POLB P06746 1/20 0.57
RAB9A P51151 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
CES2 O00748 2/20 0.55
CES1 P23141 2/20 0.55
KDM4E B2RXH2 1/20 0.55
XDH P47989 1/20 0.54
RXRA P19793 1/20 0.53
CHEK1 O14757 1/20 0.53
PARP1 P09874 1/20 0.52
PARP10 Q53GL7 1/20 0.52
PARP2 Q9UGN5 1/20 0.52
PARP4 Q9UKK3 1/20 0.52
TAS2R14 Q9NYV8 2/20 0.51
PLA2G4B P0C869 1/20 0.50
KMT2A Q03164 1/20 0.50
ALDH1A1 P00352 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
P-Anisic Acid SCHEMBL43335 0.88 CA1 (1.00) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL1157044 0.88 CA1 (1.00) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL2130101 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL38654440 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL29790432 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL15548197 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL17891327 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL1043957 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL846287 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A
P-Anisic Acid SCHEMBL414716 0.86 CA1 (0.95) CA1CA2NPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050269563-A1 Fullerodendrimer-comprising film ECODEVICE LABORATORY CO., LTD. (JP) 2005-12-08 US disclosed
US-20040175568-A1 Can be applied to organic semiconductor devices utilizing the optophysicochemical characteristics of fullerene, and in particular, to solar panel materials, organic EL materials, photorefractive polymers, electrophotographic light-sensitive materials, film materials having environmental cleansing actions ECODEVICE LABORATORY CO., LTD. (JP) 2004-09-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050269563-A1 Fullerodendrimer-comprising film TOMM70, SCO2, S100A10 CA1 274/4885CA2 3134/4885NPC1 1366/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.